A Cyanine-Bridged Somatostatin Hybrid Probe for Multimodal SSTR2 Imaging in Vitro and in Vivo: Synthesis and Evaluation.
Animals
Carbocyanines
/ chemistry
Cell Line, Tumor
Fluorescent Dyes
/ chemical synthesis
Humans
Mice
Mice, Nude
Neuroendocrine Tumors
/ diagnostic imaging
Octreotide
/ analogs & derivatives
Organometallic Compounds
/ chemistry
Peptides
/ chemistry
Positron-Emission Tomography
Radiopharmaceuticals
/ chemistry
Receptors, Somatostatin
/ chemistry
Somatostatin
/ chemistry
Transplantation, Heterologous
SSTR2
cyanines
fluorescence
multimodal imaging
octreotate
Journal
Chembiochem : a European journal of chemical biology
ISSN: 1439-7633
Titre abrégé: Chembiochem
Pays: Germany
ID NLM: 100937360
Informations de publication
Date de publication:
06 04 2021
06 04 2021
Historique:
received:
23
11
2020
pubmed:
26
11
2020
medline:
18
11
2021
entrez:
25
11
2020
Statut:
ppublish
Résumé
Multimodal imaging probes have attracted the interest of ongoing research, for example, for the surgical removal of tumors. Modular synthesis approaches allow the construction of hybrid probes consisting of a radiotracer, a fluorophore and a targeting unit. We present the synthesis of a new asymmetric bifunctional cyanine dye that can be used as a structural and functional linker for the construction of such hybrid probes.
Identifiants
pubmed: 33238069
doi: 10.1002/cbic.202000791
pmc: PMC8048842
doi:
Substances chimiques
Carbocyanines
0
Fluorescent Dyes
0
Ga(III)-DOTATOC
0
Organometallic Compounds
0
Peptides
0
Radiopharmaceuticals
0
Receptors, Somatostatin
0
SSTR2 protein, human
0
Somatostatin
51110-01-1
Octreotide
RWM8CCW8GP
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1307-1315Subventions
Organisme : Dahlem Research School
Organisme : Studienstiftung des Deutschen Volkes
Organisme : Deutsche Forschungsgemeinschaft
Informations de copyright
© 2020 The Authors. ChemBioChem published by Wiley-VCH GmbH.
Références
Theranostics. 2019 Feb 14;9(5):1336-1347
pubmed: 30867834
Bioconjug Chem. 2019 Mar 20;30(3):888-897
pubmed: 30742423
Nuklearmedizin. 2016;55(2):41-50
pubmed: 27067792
Angew Chem Int Ed Engl. 2015 May 11;54(20):5981-4
pubmed: 25800807
Neuroendocrinology. 2004;80 Suppl 1:51-6
pubmed: 15477718
Chemistry. 2020 Aug 21;26(47):10871-10881
pubmed: 32315486
Biomaterials. 2010 Apr;31(11):3016-22
pubmed: 20092887
ACS Med Chem Lett. 2017 Jun 06;8(7):720-725
pubmed: 28740605
Acta Pharm Sin B. 2018 May;8(3):320-338
pubmed: 29881672
Bioconjug Chem. 2016 Jan 20;27(1):257-63
pubmed: 26684717
Mol Pharm. 2019 Mar 4;16(3):1412-1420
pubmed: 30714739
J Nucl Med. 2016 Aug;57(8):1289-95
pubmed: 27127222
Pancreas. 2013 Aug;42(6):937-43
pubmed: 23587853
Chembiochem. 2021 Apr 6;22(7):1307-1315
pubmed: 33238069
Chemistry. 2017 Jul 12;23(39):9306-9312
pubmed: 28339120
J Nucl Med. 2019 Jan;60(1):71-78
pubmed: 30237214
EJNMMI Res. 2015 Apr 10;5:22
pubmed: 25918675
Tumour Biol. 2017 Jun;39(6):1010428317705519
pubmed: 28618966
Bioconjug Chem. 2008 Jan;19(1):192-200
pubmed: 18020401
J Med Chem. 2018 May 10;61(9):4256-4262
pubmed: 29676909
Eur J Nucl Med. 2000 Mar;27(3):273-82
pubmed: 10774879
Theranostics. 2018 Mar 8;8(8):2161-2170
pubmed: 29721070
J Org Chem. 2014 Jun 20;79(12):5511-20
pubmed: 24845528
Angew Chem Int Ed Engl. 2018 Aug 13;57(33):10646-10650
pubmed: 29905400
Bioconjug Chem. 2010 Oct 20;21(10):1709-19
pubmed: 20812730
J Nucl Med. 2017 Jan;58(1):29-35
pubmed: 27516447
J Nucl Med. 2017 Nov;58(11):1858-1864
pubmed: 28572490
Bioconjug Chem. 2015 Apr 15;26(4):773-81
pubmed: 25811535
Bioconjug Chem. 2016 May 18;27(5):1253-8
pubmed: 27074375
Trends Pharmacol Sci. 2013 Dec;34(12):676-88
pubmed: 24183675
J Nucl Med. 2011 Dec;52(12):1864-70
pubmed: 22072704
Biomed Res Int. 2014;2014:153741
pubmed: 24822177
Biochem J. 1963 Oct;89:114-23
pubmed: 14097352
Front Endocrinol (Lausanne). 2018 Apr 06;9:146
pubmed: 29681888
Nucl Med Rev Cent East Eur. 2011;14(2):85-9
pubmed: 22219148
Am J Nucl Med Mol Imaging. 2018 Oct 20;8(5):311-331
pubmed: 30510849
Clin Cancer Res. 2019 Jul 15;25(14):4332-4342
pubmed: 31015345
Int J Cancer. 2002 Apr 20;98(6):930-7
pubmed: 11948475
J Med Chem. 2020 Mar 12;63(5):2426-2433
pubmed: 31855417
J Nucl Med. 2020 Feb;61(2):234-241
pubmed: 31481575
J Nucl Med. 2015 Jul;56(7):1100-5
pubmed: 25977461
J Nucl Med. 2019 Apr;60(4):459-465
pubmed: 30733318